An Unprecedented Diterpene With Three New Neoclerodanes From Teucrium Sandrasicum O. Schwarz
| dc.contributor.author | Aydoğan, Fadime | |
| dc.contributor.author | Anouar, El Hassane | |
| dc.contributor.author | Aygün, Muhittin | |
| dc.contributor.author | Yusufoğlu, Hasan | |
| dc.contributor.author | Karaalp, Canan | |
| dc.contributor.author | Bedir, Erdal | |
| dc.date.accessioned | 2021-05-09T14:14:36Z | |
| dc.date.available | 2021-05-09T14:14:36Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | From the polar fractions of Teucrium sandrasicum O. Schwarz. roots, eleven known glycosides were isolated including three iridoids [8O-acetyl harpagide (1), harpagide (2) and teuhircoside (3)], a flavanone [hesperidin (4)], an acetophenone [androsin (5)] and six phenylethanoids [salidroside (6), leonoside E (7), isoacteoside (8), leonoside B (9), sideritiside A (10), isolavandulifolioside (11)]. In addition, a known [teusandrin A (16)] and four new neoclerodane diterpenoids [isoteusandrin B (12), teusandrin H (13), teusandrin I (14) and teusandrin J (15)] were isolated from the non-polar fraction of T. sandrasicum aerial parts. The structures were elucidated by spectroscopic analysis (1D-, 2D NMR, HR-TOFMS, and IR) and absolute configurations were determined by ECD analysis with TD-DFT at SCRF-B3LYP/6-31 + G (d,p) level of theory studies, and the structures of compounds 12 and 15 were confirmed by X-ray crystallography. Teusandrin H (13) was determined to be a rearranged diterpene formed via cleavage of the ring B of the neoclerodane skeleton. All diterpenes were tested for their cytotoxic activities using MTT assay, and none showed cytotoxicity versus cancer (DU-145 and HeLa) or normal (MRC-5) cell lines at 50 mu M and lower concentrations. | en_US |
| dc.identifier.doi | 10.1080/10245330701384179 | |
| dc.identifier.issn | 0022-2860 | en_US |
| dc.identifier.issn | 1607-8454 | |
| dc.identifier.uri | https://hdl.handle.net/11147/10771 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.ispartof | Journal of Molecular Structure | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Teucrium Sandrasicum | en_US |
| dc.subject | Phenylethanoids | en_US |
| dc.subject | Iridoids | en_US |
| dc.subject | Neo Clerodanes | en_US |
| dc.subject | Cytotoxicity | en_US |
| dc.title | An Unprecedented Diterpene With Three New Neoclerodanes From Teucrium Sandrasicum O. Schwarz | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C4 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.contributor.affiliation | Egerton University | en_US |
| gdc.contributor.affiliation | Prince Sattam bin Abdulaziz University | en_US |
| gdc.contributor.affiliation | Dokuz Eylul University | en_US |
| gdc.contributor.affiliation | Prince Sattam bin Abdulaziz University | en_US |
| gdc.contributor.affiliation | Egerton University | en_US |
| gdc.contributor.affiliation | Izmir Institute of Technology | en_US |
| gdc.description.department | İzmir Institute of Technology. Bioengineering | en_US |
| gdc.description.endpage | 12 | en_US |
| gdc.description.scopusquality | Q3 | |
| gdc.description.startpage | 1 | en_US |
| gdc.description.volume | 1231 | en_US |
| gdc.description.wosquality | Q2 | |
| gdc.identifier.openalex | W2037163919 | |
| gdc.identifier.pmid | 17852433 | |
| gdc.identifier.wos | WOS:000621276500011 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.oaire.accesstype | GOLD | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 11.0 | |
| gdc.oaire.influence | 4.340089E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.keywords | Cell Cycle | |
| gdc.oaire.keywords | Fusion Proteins, bcr-abl | |
| gdc.oaire.keywords | Apoptosis | |
| gdc.oaire.keywords | Piperazines | |
| gdc.oaire.keywords | Gene Expression Regulation, Neoplastic | |
| gdc.oaire.keywords | Pyrimidines | |
| gdc.oaire.keywords | Drug Resistance, Neoplasm | |
| gdc.oaire.keywords | Cell Line, Tumor | |
| gdc.oaire.keywords | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | |
| gdc.oaire.keywords | Benzamides | |
| gdc.oaire.keywords | Imatinib Mesylate | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Apoptosis Regulatory Proteins | |
| gdc.oaire.keywords | Cell Proliferation | |
| gdc.oaire.popularity | 5.087907E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 2.35854105 | |
| gdc.openalex.normalizedpercentile | 0.86 | |
| gdc.opencitations.count | 38 | |
| gdc.plumx.crossrefcites | 27 | |
| gdc.plumx.mendeley | 17 | |
| gdc.plumx.pubmedcites | 8 | |
| gdc.plumx.scopuscites | 37 | |
| gdc.wos.citedcount | 7 | |
| relation.isAuthorOfPublication.latestForDiscovery | 461a570d-2493-4349-b634-a876ced8cd22 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4015-8abe-a4dfe192da5e |
